Company

Xeno Transplants Corp

Headquarters: Brookline, MA, United States

OTC: XENO

Detailed Description

Xeno Transplants Corporation operates as a bio-technology research and development company. The company, through a license agreement with Massachusetts General Hospital, intends to develop, manufacture, distribute, and use products and processes for public use with regard to xenotransplantation. The Xenotransplantation is intended to address the problems arising from the limited supply of available human cells, tissues, and organs for transplantation by developing technologies to permit the transplantation of cells, tissues, and organs from other species into humans, such as swine. Xeno Transplants Corporation was incorporated in 2004 and is based in Brookline, Massachusetts.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Xeno Transplants Corp has the following listings and related stock indices.


Stock: OTC: XENO wb_incandescent

Details

Headquarters:

143 Gardner Road

Brookline, MA 02445

United States

Phone: 617-566-5228